Works by Zhang, Lele

Results: 227
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Clinical research progress of spinal epidural lipomatosis.

    Published in:
    Chinese Journal of Reparative & Reconstructive Surgery, 2023, v. 37, n. 10, p. 1284, doi. 10.7507/1002-1892.202305071
    By:
    • ZHANG Lele;
    • XU Yuzhu;
    • FAN Pan;
    • LI Xi;
    • WANG Jiadong;
    • TAO Yuao;
    • LI Xiaolong;
    • WANG Yuntao
    Publication type:
    Article
    31
    32
    33
    34

    Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial.

    Published in:
    BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02696-4
    By:
    • Zhu, Xinsheng;
    • Sun, Liangdong;
    • Song, Nan;
    • He, Wenxin;
    • Xie, Boxiong;
    • Hu, Junjie;
    • Zhang, Jing;
    • Yang, Jie;
    • Dai, Jie;
    • Bian, Dongliang;
    • Xia, Haoran;
    • Sun, Fenghuan;
    • Xiong, Anwen;
    • Luo, Jie;
    • Zhang, Lele;
    • Yu, Huansha;
    • Liu, Ming;
    • Liu, Hongcheng;
    • Wang, Haifeng;
    • Zhang, Haiping
    Publication type:
    Article
    35

    Remote Quantification of the Trophic Status of Chinese Lakes.

    Published in:
    Hydrology & Earth System Sciences Discussions, 2022, p. 1, doi. 10.5194/hess-2022-91
    By:
    • Sijia Li;
    • Shiqi Xu;
    • Kaishan Song;
    • Kutser, Tiit;
    • Zhidan Wen;
    • Ge Liu;
    • Yingxin Shang;
    • Lili Lyu;
    • Hui Tao;
    • Xiang Wang;
    • Lele Zhang;
    • Fangfang Chen
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01861-w
    By:
    • Xia, Haoran;
    • Zhang, Han;
    • Ruan, Zheng;
    • Zhang, Huibiao;
    • Sun, Liangdong;
    • Chen, Hezhong;
    • Zhou, Yongxin;
    • Zhang, Lele;
    • Bian, Dongliang;
    • Zhu, Xinsheng;
    • Zhang, Jing;
    • Sun, Fenghuan;
    • Yu, Huansha;
    • Song, Nan;
    • Liu, Xiaogang;
    • Zhu, Yuming;
    • Zhang, Haiping;
    • He, Wenxin;
    • Chen, Jian;
    • Yang, Jie
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50